Cancer Research3d
Update on Whole-Body MRI Surveillance for Pediatric Cancer Predisposition Syndromes
Deep learning (DL) delineation of the prostate gland and prostate cancer detection on PSMA PET/CT: results from prospective, randomised, multi-centre pro-PSMA trial ...
Cancer Research3d
American Association for Cancer Research
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...
Cancer Research3d
Metabolic Tumor Volume Response after Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma
1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. 9Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York ...
Cancer Research3d
Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group
1Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. 2Michael Smith Genome Sciences Centre and Clinical Cancer Genomics ...
Cancer Research3d
The Intrauterine Device: How to Deploy This Strategy in the Molecular World?
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. 2Department of Medicine, Weill Cornell Medical College, New York, New York. *Corresponding Author: Claire F.
Cancer Research3d
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma
1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. *Corresponding Author: Jaleh Fallah, U.S. Center for Drug Evaluation and Research, Office of New ...
Cancer Research4d
T Cells Home to Intracranial Metastases Via ICAM-1 + Peritumoral Venous Vessels
Major Finding: Antitumor T cells are recruited to intracranial metastases through ICAM-1 + peritumoral venous vessels (PVV). Concept: PVVs mediate T-cell recruitment and motility, which can be ...
Cancer Research4d
The UBA1-STUB1 axis mediates cancer immune escape and resistance to checkpoint blockade
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license ...
Cancer Research4d
Merck Buys Bispecific Antibody for up to $3.3 Billion
Today, Merck announced that it will acquire LaNova Medicines’ PD-1/VEGF bispecific antibody, LM-299, for $588 million upfront plus financial awards that could reach $2.7 billion if certain development ...
Cancer Research5d
Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model
Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Research5d
Abstract B067: Dynamic chromatin landscapes of colorectal cancer development and cell-free DNA fragmentation
Search for other works by this author on: ...
Cancer Research5d
AKT and EZH2 Inhibition Co-opts Mammary Gland Involution to Target TNBC
Major Finding: AKT and EZH2 inhibitors synergistically induce apoptosis and regression in triple negative breast cancer (TNBC). Concept: The combination drives luminal differentiation that sensitizes ...